600319.SS
Weifang Yaxing Chemical Co., Ltd. [600319.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600319.SS Stock Summary
Top 10 Correlated ETFs
600319.SS
Top 10 Correlated Stocks
600319.SS
In the News
600319.SS Financial details
Company Rating
Strong Buy
Market Cap
1.81B
Income
16.19M
Revenue
824.85M
Book val./share
1.66
Cash/share
0.1
Dividend
-
Dividend %
-
Employees
849
Optionable
No
Shortable
Yes
Earnings
29 Apr 2021
P/E
-96.87
Forward P/E
-
PEG
11.23
P/S
2.52
P/B
3.88
P/C
38.5
P/FCF
-6.89
Quick Ratio
0.16
Current Ratio
0.28
Debt / Equity
1.14
LT Debt / Equity
0.04
-
-
EPS (TTM)
0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-94.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-13%
Revenue Q/Q
-2.32%
EPS Q/Q
-364.11%
-
-
-
-
SMA20
-
SMA50
-20%
SMA100
-20%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-4%
ROC
-0.03%
Gross Margin
4%
Oper. Margin
-3%
Profit Margin
-3%
Payout
-171%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.88-6.37
52W High
-35.83%
52W Low
+92.5%
RSI
41
Rel Volume
0.59
Avg Volume
12.91M
Volume
7.57M
Perf Week
-20.78%
Perf Month
-1.79%
Perf Quarter
-17.74%
Perf Half Y
-21.75%
-
-
-
-
Beta
0.573
-
-
Volatility
0.38%, 0.37%
Prev Close
0%
Price
3.85
Change
-1.28%
600319.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.24 | 0.16 | 0.61 | 2.41 | 2.13 | |
| Net income per share | -0.17 | -0.06 | 0.61 | 0.31 | 0.02 | |
| Operating cash flow per share | 0.6 | -0.11 | -0.26 | 0.35 | -0.43 | |
| Free cash flow per share | 0.58 | -1.07 | -0.97 | 0 | -1.07 | |
| Cash per share | 1 | 0.05 | 0.28 | 0.22 | 0.1 | |
| Book value per share | 0.2 | 0.12 | 0.73 | 1.82 | 1.66 | |
| Tangible book value per share | 0.2 | -0.33 | 0.28 | 1.4 | 0.94 | |
| Share holders equity per share | 0.2 | 0.12 | 0.73 | 1.82 | 1.66 | |
| Interest debt per share | 3.33 | 2.3 | 2.54 | 1.61 | 2.02 | |
| Market cap | 1.46B | 1.64B | 1.75B | 1.93B | 2.26B | |
| Enterprise value | 1.99B | 2.35B | 2.4B | 2.38B | 2.95B | |
| P/E ratio | -26.97 | -94.03 | 9.07 | 17.77 | 354.54 | |
| Price to sales ratio | 0.88 | 33.23 | 9.09 | 2.29 | 2.74 | |
| POCF ratio | 7.77 | -46.08 | -20.97 | 15.73 | -13.45 | |
| PFCF ratio | 7.93 | -4.83 | -5.72 | -6.78K | -5.42 | |
| P/B Ratio | 22.63 | 42.18 | 7.56 | 3.03 | 3.5 | |
| PTB ratio | 22.63 | 42.18 | 7.56 | 3.03 | 3.5 | |
| EV to sales | 1.2 | 47.64 | 12.43 | 2.81 | 3.58 | |
| Enterprise value over EBITDA | 11.22 | -82.74 | 8.51 | 17.83 | 23.76 | |
| EV to operating cash flow | 10.56 | -66.07 | -28.68 | 19.33 | -17.58 | |
| EV to free cash flow | 10.78 | -6.93 | -7.83 | -8.34K | -7.08 | |
| Earnings yield | -0.04 | -0.01 | 0.11 | 0.06 | 0 | |
| Free cash flow yield | 0.13 | -0.21 | -0.17 | 0 | -0.18 | |
| Debt to equity | 15.46 | 18.71 | 3.15 | 0.82 | 1.14 | |
| Debt to assets | 0.78 | 0.4 | 0.41 | 0.27 | 0.35 | |
| Net debt to EBITDA | 2.96 | -25.03 | 2.29 | 3.33 | 5.58 | |
| Current ratio | 0.48 | 0.09 | 0.22 | 0.3 | 0.26 | |
| Interest coverage | 2.13 | -188.84K | 3.72 | 1.73 | 0.13 | |
| Income quality | 6.43 | 1.38 | -0.43 | 1.13 | -26.73 | |
| Dividend Yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
| Payout ratio | -0.93 | -2.39 | 0.27 | 0.45 | 7.03 | |
| Sales general and administrative to revenue | 0.03 | 1.45 | -0.08 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0.05 | 0.03 | 0.01 | 0.01 | |
| Intangibles to total assets | 0 | 0.08 | 0.08 | 0.08 | 0.13 | |
| Capex to operating cash flow | -0.02 | 8.54 | 2.66 | -1 | 1.48 | |
| Capex to revenue | 0 | -6.16 | -1.16 | -0.15 | -0.3 | |
| Capex to depreciation | -0.06 | -54.72 | -10.28 | -2.35 | -3.87 | |
| Stock based compensation to revenue | 0 | 0 | 0.07 | 0 | 0 | |
| Graham number | 0.89 | 0.39 | 3.18 | 3.56 | 0.78 | |
| ROIC | -0.2 | -0.03 | 0.27 | 0.06 | 0 | |
| Return on tangible assets | -0.04 | -0.01 | 0.12 | 0.06 | 0 | |
| Graham Net | -2.49 | -5.43 | -4.24 | -2.99 | -3.26 | |
| Working capital | -538.51M | -1.09B | -1.13B | -729.69M | -840.66M | |
| Tangible asset value | 63.82M | -103.43M | 89.75M | 490.87M | 364.25M | |
| Net current asset value | -715.96M | -1.66B | -1.23B | -962.28M | -1.17B | |
| Invested capital | 15.46 | 18.71 | 3.15 | 0.82 | 1.14 | |
| Average receivables | 161.81M | 53.38M | 69.33M | 131.28M | 134.46M | |
| Average payables | 174.08M | 248.44M | 392.28M | 412.62M | 387M | |
| Average inventory | 121.47M | 73.76M | 60.53M | 79.86M | 110.07M | |
| Days sales outstanding | 20.02 | 118.39 | 232.35 | 60.3 | 57.1 | |
| Days payables outstanding | 26.59 | 3.22K | 744.53 | 221.01 | 154.46 | |
| Days of inventory on hand | 23.36 | 455.87 | 124.27 | 48.11 | 57.01 | |
| Receivables turnover | 18.23 | 3.08 | 1.57 | 6.05 | 6.39 | |
| Payables turnover | 13.73 | 0.11 | 0.49 | 1.65 | 2.36 | |
| Inventory turnover | 15.62 | 0.8 | 2.94 | 7.59 | 6.4 | |
| ROE | -0.84 | -0.45 | 0.83 | 0.17 | 0.01 | |
| Capex per share | -0.01 | -0.96 | -0.71 | -0.35 | -0.64 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.59 | 0.53 | 0.55 | 0.53 | 0.52 | |
| Net income per share | 0.12 | -0.02 | -0.07 | -0.08 | 0.22 | |
| Operating cash flow per share | 0.12 | -0.02 | -0.21 | -0.05 | -0.11 | |
| Free cash flow per share | 0.09 | -0.1 | -0.58 | -0.23 | -0.14 | |
| Cash per share | 0.2 | 0.58 | 0.6 | 0.21 | 0.1 | |
| Book value per share | 1.64 | 1.6 | 1.53 | 1.44 | 1.66 | |
| Tangible book value per share | 1.27 | 1.23 | 1.16 | 0.71 | 0.94 | |
| Share holders equity per share | 1.64 | 1.6 | 1.53 | 1.44 | 1.66 | |
| Interest debt per share | 1.36 | 1.63 | 1.87 | 1.84 | 1.93 | |
| Market cap | 2.14B | 2.3B | 1.95B | 1.99B | 2.26B | |
| Enterprise value | 2.58B | 2.7B | 2.43B | 2.6B | 2.95B | |
| P/E ratio | 11.52 | -64.94 | -17.63 | -15.36 | 6.64 | |
| Price to sales ratio | 9.28 | 11.25 | 9.07 | 9.67 | 11.25 | |
| POCF ratio | 46.09 | -259.76 | -24.05 | -101.25 | -53.1 | |
| PFCF ratio | 59.91 | -62.42 | -8.73 | -22.61 | -42.73 | |
| P/B Ratio | 3.35 | 3.71 | 3.29 | 3.55 | 3.5 | |
| PTB ratio | 3.35 | 3.71 | 3.29 | 3.55 | 3.5 | |
| EV to sales | 11.21 | 13.2 | 11.32 | 12.68 | 14.7 | |
| Enterprise value over EBITDA | 339.67 | -304.1 | -162.05 | -141.73 | 28.86 | |
| EV to operating cash flow | 55.66 | -304.87 | -30 | -132.86 | -69.4 | |
| EV to free cash flow | 72.35 | -73.26 | -10.89 | -29.67 | -55.84 | |
| Earnings yield | 0.02 | 0 | -0.01 | -0.02 | 0.04 | |
| Free cash flow yield | 0.02 | -0.02 | -0.11 | -0.04 | -0.02 | |
| Debt to equity | 0.82 | 1.01 | 1.21 | 1.25 | 1.14 | |
| Debt to assets | 0.27 | 0.3 | 0.32 | 0.33 | 0.35 | |
| Net debt to EBITDA | 58.41 | -45 | -32.15 | -33.71 | 6.78 | |
| Current ratio | 0.3 | 0.45 | 0.44 | 0.28 | 0.26 | |
| Interest coverage | 6.39 | -1.9 | -2.25 | -2.24 | 5.81 | |
| Income quality | 1 | 1 | 2.93 | 0.61 | -0.5 | |
| Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.17 | -0.81 | -0.36 | -0.41 | 0.17 | |
| Sales general and administrative to revenue | -0.08 | 0.05 | -0.02 | 0.13 | -0.1 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.08 | 0.07 | 0.07 | 0.13 | 0.13 | |
| Capex to operating cash flow | -0.23 | 3.16 | 1.76 | 3.48 | 0.24 | |
| Capex to revenue | -0.05 | -0.14 | -0.66 | -0.33 | -0.05 | |
| Capex to depreciation | -0.79 | -1.97 | -10.01 | 2.41 | -0.58 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.1 | 0.91 | 1.56 | 1.64 | 2.86 | |
| ROIC | 0.04 | -0.01 | -0.02 | -0.02 | 0.05 | |
| Return on tangible assets | 0.03 | 0 | -0.01 | -0.02 | 0.05 | |
| Graham Net | -2.7 | -2.77 | -3.19 | -3.53 | -3.26 | |
| Working capital | -729.69M | -555.96M | -650.2M | -841.29M | -840.66M | |
| Tangible asset value | 490.87M | 475.25M | 448.15M | 275.89M | 364.25M | |
| Net current asset value | -962.28M | -987.31M | -1.13B | -1.27B | -1.17B | |
| Invested capital | 0.82 | 1.01 | 1.21 | 1.25 | 1.14 | |
| Average receivables | 129.28M | 139.42M | 148.69M | 133.88M | 119.2M | |
| Average payables | 431.27M | 413.76M | 378.3M | 364.78M | 354.35M | |
| Average inventory | 99.86M | 92.92M | 99.11M | 112.58M | 122.23M | |
| Days sales outstanding | 54.7 | 61.19 | 66.46 | 47.93 | 57.9 | |
| Days payables outstanding | 190.09 | 179.69 | 152.95 | 160.67 | 161.99 | |
| Days of inventory on hand | 41.38 | 41.71 | 45.05 | 51.82 | 59.79 | |
| Receivables turnover | 1.65 | 1.47 | 1.35 | 1.88 | 1.55 | |
| Payables turnover | 0.47 | 0.5 | 0.59 | 0.56 | 0.56 | |
| Inventory turnover | 2.17 | 2.16 | 2 | 1.74 | 1.51 | |
| ROE | 0.07 | -0.01 | -0.05 | -0.06 | 0.13 | |
| Capex per share | -0.03 | -0.07 | -0.37 | -0.18 | -0.03 |
600319.SS Frequently Asked Questions
What is Weifang Yaxing Chemical Co., Ltd. stock symbol ?
Weifang Yaxing Chemical Co., Ltd. is a CN stock and trading under the symbol 600319.SS
What is Weifang Yaxing Chemical Co., Ltd. stock quote today ?
Weifang Yaxing Chemical Co., Ltd. stock price is $3.85 today.
Is Weifang Yaxing Chemical Co., Ltd. stock public?
Yes, Weifang Yaxing Chemical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 12.91M
- Market Capitalization 1.81B
- Employee 849
- CEO Mr. Wei Dong Lu
- Headquarters Weifang,CN
- IPO Date 2001-03-26
-
Website
https://www.chinayaxing.com 
Weifang Yaxing Chemical Co., Ltd. engages in the research and development, production, operation, import, and sale of chemical materials in China and internationally. It offers chlorinated polyethylene CPE, azodicarbonamide foaming agent, industrial hydrazine hydrate, sodium hydroxide, liquid chlorine, and hydrochloric acid. The company was founded in 1994 and is headquartered in Weifang, China.
